Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC)

Lung Cancer

Volumn 49, Issue 1, 2005, Pages 71-76

  Görn, Michael ^a   Anige, Manuela ^a   Burkholder, Iris ^b   Müller, Beate ^a   Scheffler, Antje ^a   Edler, Lutz ^b   Boeters, Ina ^a   Panse, Jens ^a   Schuch, Gunter ^a   Hossfeld, Dieter Kurt ^a   Laack, Eckart ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Advanced NSCLC; ELISA; Prognostic factor; ROBO 4

Indexed keywords

MAGIC ROUNDABOUT PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; AGED; ANTIBODIES; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20444376928     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.12.005     Document Type: Article

References (17)

1. D.M. Parkin The global burden of cancer Semin Cancer Biol 8 1998 219 235
2. H. Bülzebruck, R. Bopp, P. Drings, E. Bauer, S. Krysa, and G. Probst New aspects in the staging of lung cancer Cancer 70 1992 1102 1110
3. F. Clifton, and C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1711 1717
4. D.M. Finkelstein, D.S. Ettinger, and J.C. Ruckdeschel Long-term survivors in metastatic non-small cell lung cancer: an Eastern Cooperative Oncology Group J Clin Oncol 4 1986 702 709
5. J.P. O'Connell, M.G. Kris, R.J. Gralla, S. Groshen, A. Trust, and J.J. Fiore Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy J Clin Oncol 4 1986 1604 1614
6. M. Sakurai, T. Shinkai, K. Eguchi, Y. Sasaki, T. Yamura, and K. Miura Prognostic factors in non-small cell lung cancer: multiregression analysis in the National Cancer Center Hospital (Japan) J Cancer Res Clin Oncol 113 1987 563 566
7. J. Folkman, K. Watson, D. Ingbher, and D. Hanahan Induction of angiogenesis during the transition from hyperplasia to neoplasia Nature 339 1989 58 59
8. M. Toi, S. Hoshina, T. Takayanagi, and T. Tominaga Association of vascular endothelial growth factor expression with tumor angiogenesis and early relapse in primary breast cancer Jpn J Cancer Res 85 1994 1045 1049
9. K. Maeda, Y.S. Chung, Y. Ogawa, S. Takatsuka, S.M. Kang, and M. Ogawa Prognostic value of vascular endothelial growth factor expression in gastric carcinoma Cancer 77 1996 858 863
10. M. Volm, R. Koomagi, and J. Mattern Prognostic value of vascular endothelial growth factor and its receptor FLT-1 in squamous cell lung cancer Int J Cancer 74 1997 64 68
11. L. Huminiecki, and R. Bicknell In silico cloning of novel endothelial-specific genes Genome Res 10 2000 1796 1808
12. L. Huminiecki, M. Gorn, S. Suchting, R. Poulsom, and R. Bicknell Magic Roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis Genomics 79 2002 547 552
13. E. Laack, N. Dickgreber, T. Muller, A. Knuth, J. Benk, and C. Lorenz Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine and cisplatin in the treatment of advanced non-small cell lung cancer: from the German and Swiss Lung Cancer Study Group J Clin Oncol 22 2004 2348 2356
14. K.W. Park, C.M. Morrison, L.K. Sorensen, C.A. Jones, Y. Rao, and C.B. Chien Robo4 is a vascular-specific receptor that inhibits endothelial migration Dev Biol 261 2003 251 267
15. A. Dallol, N.F. Da Silva, P. Viacava, J.D. Minna, J. Biechle, and E.R. Maher Slit2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers Cancer Res 62 2002 5874 5880
16. A. Dallol, D. Morton, E.R. Maher, and F. Latif Slit2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells Cancer Res 63 2003 1054 1058
17. E. Gunsilius, A. Petzer, G. Stockhammer, W. Nussbaumer, P. Schumacher, and J. Clausen Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood Oncology 58 2000 169 174